|
|
|
| 
|
|
|
My Recent Searches
|
|
|
|
|
|
|
|
|
Zynerba Pharmaceuticals, Inc. (ZYNE) |
|
|
$1.30 0.00 (0.00%) as of 4:30 Tue 10/10
|
|
Download |
|
|
| |
| |
| Exchange: |
N/A |
| Security
Type: |
N/A |
| Shares
Out: |
29,440,000 |
| Market
Cap: |
38.27(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$0.3 - $1.39 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Zynerba Pharmaceuticals is engaged in pharmaceutically-produced transdermal cannabinoid therapies for neuropsychiatric disorders. Co. is focused on improving the lives of patients and their families living with severe, chronic health conditions including Fragile X syndrome (FXS), autism spectrum disorder (ASD), and 22q11.2 deletion syndrome (22q). Co. is developing Zygel, the pharmaceutically-produced cannabidiol formulated as a permeation-enhanced gel for transdermal delivery and manufactured without the presence of tetrahydrocannabinol. Zygel is being developed as a clear gel with once- or twice-daily dosing and is targeting treatment of behavioral symptoms of FXS, ASD and 22q.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
48,835 |
173,289 |
| Total Sell Value |
$0 |
$0 |
$64,066 |
$153,697 |
| Total People Sold |
0 |
0 |
11 |
12 |
| Total Sell Transactions |
0 |
0 |
11 |
26 |
| End Date |
2024-02-11 |
2023-11-10 |
2023-05-12 |
2022-05-12 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Sebree Terri B |
President |
• – – |
2022-07-19 |
4 |
S |
$1.10 |
$9,109 |
D/D |
(8,281) |
367,865 |
|
51% |
|
| Rosenberger Brian |
VP, Commercial & Business Dev. |
• – – |
2022-07-18 |
4 |
A |
$0.00 |
$0 |
D/D |
14,800 |
111,800 |
|
- |
|
| Fickenscher James E |
Chief Financial Officer |
• – – |
2022-07-18 |
4 |
A |
$0.00 |
$0 |
D/D |
20,800 |
178,518 |
|
- |
|
| Anido Armando |
Chairman & CEO |
• • – |
2022-07-18 |
4 |
A |
$0.00 |
$0 |
D/D |
43,164 |
623,587 |
|
- |
|
| Sebree Terri B |
President |
• – – |
2022-07-18 |
4 |
A |
$0.00 |
$0 |
D/D |
30,000 |
376,146 |
|
- |
|
| Butler John P. |
Director |
– • – |
2022-06-14 |
4 |
S |
$1.01 |
$54 |
D/D |
(53) |
33,056 |
|
35% |
|
| Butler John P. |
Director |
– • – |
2022-06-14 |
4 |
A |
$0.00 |
$0 |
D/D |
23,109 |
33,109 |
|
- |
|
| Stephenson Pamela |
Director |
– • – |
2022-06-14 |
4 |
S |
$1.01 |
$40 |
D/D |
(40) |
28,069 |
|
35% |
|
| Stephenson Pamela |
Director |
– • – |
2022-06-14 |
4 |
A |
$0.00 |
$0 |
D/D |
23,109 |
28,109 |
|
- |
|
| Cooper Warren D |
Director |
– • – |
2022-06-14 |
4 |
S |
$1.01 |
$40 |
D/D |
(40) |
28,069 |
|
35% |
|
| Cooper Warren D |
Director |
– • – |
2022-06-14 |
4 |
A |
$0.00 |
$0 |
D/D |
23,109 |
28,109 |
|
- |
|
| Federici William J |
Director |
– • – |
2022-06-14 |
4 |
S |
$1.01 |
$40 |
D/D |
(40) |
28,069 |
|
35% |
|
| Federici William J |
Director |
– • – |
2022-06-14 |
4 |
A |
$0.00 |
$0 |
D/D |
23,109 |
28,109 |
|
- |
|
| Moch Kenneth I |
Director |
– • – |
2022-06-14 |
4 |
S |
$1.01 |
$40 |
D/D |
(40) |
28,069 |
|
35% |
|
| Moch Kenneth I |
Director |
– • – |
2022-06-14 |
4 |
A |
$0.00 |
$0 |
D/D |
23,109 |
28,109 |
|
- |
|
| Kisner Daniel L |
Director |
– • – |
2022-06-14 |
4 |
S |
$1.01 |
$40 |
D/D |
(40) |
28,069 |
|
35% |
|
| Kisner Daniel L |
Director |
– • – |
2022-06-14 |
4 |
A |
$0.00 |
$0 |
D/D |
23,109 |
28,109 |
|
- |
|
| Parker Albert P |
Chief Legal Officer |
• – – |
2022-02-14 |
4 |
A |
$0.00 |
$0 |
D/D |
35,000 |
35,000 |
|
- |
|
| Fickenscher James E |
Chief Financial Officer |
• – – |
2022-01-26 |
4 |
A |
$0.00 |
$0 |
D/D |
85,000 |
157,718 |
|
- |
|
| Anido Armando |
Chairman & Chief Exec. Officer |
• • – |
2022-01-26 |
4 |
A |
$0.00 |
$0 |
D/D |
120,000 |
580,423 |
|
- |
|
| Rosenberger Brian |
VP, Commercial & Business Dev. |
• – – |
2022-01-26 |
4 |
A |
$0.00 |
$0 |
D/D |
60,000 |
97,000 |
|
- |
|
| Sebree Terri B |
President |
• – – |
2022-01-26 |
4 |
A |
$0.00 |
$0 |
D/D |
85,000 |
346,146 |
|
- |
|
| Moch Kenneth I |
Director |
– • – |
2021-08-03 |
4 |
A |
$0.00 |
$0 |
D/D |
5,000 |
5,000 |
|
- |
|
| Kisner Daniel L |
Director |
– • – |
2021-08-03 |
4 |
A |
$0.00 |
$0 |
D/D |
5,000 |
5,000 |
|
- |
|
| Federici William J |
Director |
– • – |
2021-08-03 |
4 |
A |
$0.00 |
$0 |
D/D |
5,000 |
5,000 |
|
- |
|
139 Records found
|
|
Page 4 of 6 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
